🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Beijing Children's Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Beijing Children's Hospital as lead sponsor. Synced 26 Sep 2026
8Current trials
5Recruiting now
2Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Beijing Children's Hospital is the lead sponsor of 8 current clinical trials in our China register. 5 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Hetrombopag and Letermovir. The most-studied condition is EBV-associated T/NK-cell Lymphoproliferative Diseases.

ClinicalTrials.gov trials by status

  • Recruiting563%
  • Not yet open113%
  • Active, closed225%

Trials by phase

  • Observational450%
  • Not applicable338%
  • Phase 4113%
01

Clinical trials sponsored by Beijing Children's Hospital

8 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis
NCT07488728 · ClinicalTrials.gov ↗ · EBV-associated T/NK-cell Lymphoproliferative Diseases, Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis, Letermovir
Not applicable Recruiting 2025-10 China
The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
NCT06037473 · ClinicalTrials.gov ↗ · Growth Hormone Treatment, Growth Disorders
Observational Recruiting 2023-08 China
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
NCT06818916 · ClinicalTrials.gov ↗ · Delayed Platelet Engraftment, Neuroblastoma, Autologous Hematopoietic Stem Cell Transplantation
Not applicable Recruiting 2024-06 China
Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease
NCT07029958 · ClinicalTrials.gov ↗ · EBV-T/NK LPD
Phase 4 Recruiting 2024-11 China
Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
NCT03625739 · ClinicalTrials.gov ↗ · Tuberculosis
Observational Recruiting 2018-07 China
Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification
NCT07199101 · ClinicalTrials.gov ↗ · Radiation Dose Reduction
Not applicable Not yet open 2026-01 China
The Effectiveness and Safety of Resective Epilepsy Surgery for TRE
NCT04198181 · ClinicalTrials.gov ↗ · Tuberous Sclerosis Complex, Epilepsy
Observational Active, closed 2019-12 China
Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China
NCT07264478 · ClinicalTrials.gov ↗ · RSV Infection, Disease Burden
Observational Active, closed 2022-10 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Beijing Children's Hospital trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Beijing Children's Hospital trials

15 conditions
EBV-associated T/NK-cell Lymphoproliferative Diseases1Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis1Letermovir1Growth Hormone Treatment1Growth Disorders1Delayed Platelet Engraftment1Neuroblastoma1Autologous Hematopoietic Stem Cell Transplantation1Tuberous Sclerosis Complex1Epilepsy1EBV-T/NK LPD1RSV Infection1Disease Burden1Radiation Dose Reduction1Tuberculosis1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China85

A trial with sites in more than one country appears in each of those registers.

05

Questions about Beijing Children's Hospital trials

How many clinical trials does Beijing Children's Hospital sponsor?

Beijing Children's Hospital is the lead sponsor of 8 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Beijing Children's Hospital trials recruiting?

Yes. 5 of its 8 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Beijing Children's Hospital testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Hetrombopag (1) and Letermovir (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.